221 related articles for article (PubMed ID: 25468225)
61. Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Cabrera AR; Kirkpatrick JP; Fiveash JB; Shih HA; Koay EJ; Lutz S; Petit J; Chao ST; Brown PD; Vogelbaum M; Reardon DA; Chakravarti A; Wen PY; Chang E
Pract Radiat Oncol; 2016; 6(4):217-225. PubMed ID: 27211230
[TBL] [Abstract][Full Text] [Related]
62. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.
Sulman EP; Ismaila N; Armstrong TS; Tsien C; Batchelor TT; Cloughesy T; Galanis E; Gilbert M; Gondi V; Lovely M; Mehta M; Mumber MP; Sloan A; Chang SM
J Clin Oncol; 2017 Jan; 35(3):361-369. PubMed ID: 27893327
[TBL] [Abstract][Full Text] [Related]
63. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
[TBL] [Abstract][Full Text] [Related]
64. Glioblastoma in England: 2007-2011.
Brodbelt A; Greenberg D; Winters T; Williams M; Vernon S; Collins VP;
Eur J Cancer; 2015 Mar; 51(4):533-542. PubMed ID: 25661102
[TBL] [Abstract][Full Text] [Related]
65. Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.
Batash R; Asna N; Schaffer P; Francis N; Schaffer M
Curr Med Chem; 2017; 24(27):3002-3009. PubMed ID: 28521700
[TBL] [Abstract][Full Text] [Related]
66. Timing of surgery and bevacizumab therapy in neurosurgical patients with recurrent high grade glioma.
Abrams DA; Hanson JA; Brown JM; Hsu FP; Delashaw JB; Bota DA
J Clin Neurosci; 2015 Jan; 22(1):35-9. PubMed ID: 25481268
[TBL] [Abstract][Full Text] [Related]
67. Glioblastoma multiforme - an overview.
Urbańska K; Sokołowska J; Szmidt M; Sysa P
Contemp Oncol (Pozn); 2014; 18(5):307-12. PubMed ID: 25477751
[TBL] [Abstract][Full Text] [Related]
68. Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target.
Jackson M; Hassiotou F; Nowak A
Carcinogenesis; 2015 Feb; 36(2):177-85. PubMed ID: 25504149
[TBL] [Abstract][Full Text] [Related]
69. Glioblastoma in the elderly.
Chamberlain MC
Cancer Treat Res; 2015; 163():159-70. PubMed ID: 25468231
[TBL] [Abstract][Full Text] [Related]
70. Glioblastoma: pathology, molecular mechanisms and markers.
Aldape K; Zadeh G; Mansouri S; Reifenberger G; von Deimling A
Acta Neuropathol; 2015 Jun; 129(6):829-48. PubMed ID: 25943888
[TBL] [Abstract][Full Text] [Related]
71. Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma.
Shah JL; Li G; Shaffer JL; Azoulay MI; Gibbs IC; Nagpal S; Soltys SG
Neurosurgery; 2018 Jan; 82(1):24-34. PubMed ID: 28605463
[TBL] [Abstract][Full Text] [Related]
72. A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.
Ma DJ; Galanis E; Anderson SK; Schiff D; Kaufmann TJ; Peller PJ; Giannini C; Brown PD; Uhm JH; McGraw S; Jaeckle KA; Flynn PJ; Ligon KL; Buckner JC; Sarkaria JN
Neuro Oncol; 2015 Sep; 17(9):1261-9. PubMed ID: 25526733
[TBL] [Abstract][Full Text] [Related]
73. Peptide vaccines for the treatment of glioblastoma.
Swartz AM; Batich KA; Fecci PE; Sampson JH
J Neurooncol; 2015 Jul; 123(3):433-40. PubMed ID: 25491947
[TBL] [Abstract][Full Text] [Related]
74. Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer.
van der Mijn JC; Sol N; Mellema W; Jimenez CR; Piersma SR; Dekker H; Schutte LM; Smit EF; Broxterman HJ; Skog J; Tannous BA; Wurdinger T; Verheul HM
J Extracell Vesicles; 2014; 3():25657. PubMed ID: 25491250
[TBL] [Abstract][Full Text] [Related]
75. A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA).
Simpkins F; Drake R; Escobar PF; Nutter B; Rasool N; Rose PG
Gynecol Oncol; 2015 Feb; 136(2):240-5. PubMed ID: 25485782
[TBL] [Abstract][Full Text] [Related]
76. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
77. Glioblastoma.
Wirsching HG; Galanis E; Weller M
Handb Clin Neurol; 2016; 134():381-97. PubMed ID: 26948367
[TBL] [Abstract][Full Text] [Related]
78. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
79. Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.
Arvold ND; Tanguturi SK; Aizer AA; Wen PY; Reardon DA; Lee EQ; Nayak L; Christianson LW; Horvath MC; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Alexander BM
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):384-9. PubMed ID: 25841623
[TBL] [Abstract][Full Text] [Related]
80. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.
Dincoglan F; Beyzadeoglu M; Sager O; Demiral S; Gamsiz H; Uysal B; Ebruli C; Akin M; Oysul K; Sirin S; Dirican B
Tumori; 2015; 101(2):179-84. PubMed ID: 25791534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]